199 related articles for article (PubMed ID: 35203343)
1. Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile.
Dalla E; Bulfoni M; Cesselli D; Pravisani R; Hidaka M; Eguchi S; Baccarani U
Cells; 2022 Feb; 11(4):. PubMed ID: 35203343
[TBL] [Abstract][Full Text] [Related]
2. miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation.
Bulfoni M; Pravisani R; Dalla E; Cesselli D; Hidaka M; Di Loreto C; Eguchi S; Baccarani U
J Med Virol; 2021 Aug; 93(8):4992-5000. PubMed ID: 33818800
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected.
Cairoli V; Valle-Millares D; Terrón-Orellano MC; Luque D; Ryan P; Dominguez L; Martín-Carbonero L; De Los Santos I; De Matteo E; Ameigeiras B; Briz V; Casciato P; Preciado MV; Valva P; Fernández-Rodríguez A
J Mol Med (Berl); 2023 Nov; 101(11):1409-1420. PubMed ID: 37704856
[TBL] [Abstract][Full Text] [Related]
4. Intrahepatic MicroRNA Profile of Liver Transplant Recipients with Hepatitis C Virus Co-Infected with Human Immunodeficiency Virus.
Miyaaki H; Takatsuki M; Ichikawa T; Hidaka M; Soyama A; Ohdan H; Inomata Y; Uemoto S; Kokudo N; Nakao K; Eguchi S
Ann Transplant; 2017 Nov; 22():701-706. PubMed ID: 29170365
[TBL] [Abstract][Full Text] [Related]
5. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker.
Yousefpouran S; Mostafaei S; Manesh PV; Iranifar E; Bokharaei-Salim F; Nahand JS; Mirzaei H; Taran M; Babaei F; Sayad B; Moghoofei M
Microb Pathog; 2020 Oct; 147():104355. PubMed ID: 32569788
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection.
Gupta P; Liu B; Wu JQ; Soriano V; Vispo E; Carroll AP; Goldie BJ; Cairns MJ; Saksena NK
Virology; 2014 Feb; 450-451():336-49. PubMed ID: 24503097
[TBL] [Abstract][Full Text] [Related]
7. Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation.
Joshi D; Salehi S; Brereton H; Arno M; Quaglia A; Heaton N; O'Grady J; Agarwal K; Aluvihare V
Liver Transpl; 2013 Apr; 19(4):383-94. PubMed ID: 23408392
[TBL] [Abstract][Full Text] [Related]
8. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis viruses and liver transplantation.
Samuel D; Feray C; Bismuth H
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy.
Gupta A; Swaminathan G; Martin-Garcia J; Navas-Martin S
Viruses; 2012 Oct; 4(11):2485-513. PubMed ID: 23202492
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation in HIV/hepatitis co-infection.
Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A;
J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.
Duclos-Vallée JC; Vittecoq D; Teicher E; Feray C; Roque-Afonso AM; Lombès A; Jardel C; Gigou M; Dussaix E; Sebagh M; Guettier C; Azoulay D; Adam R; Ichaï P; Saliba F; Roche B; Castaing D; Bismuth H; Samuel D
J Hepatol; 2005 Mar; 42(3):341-9. PubMed ID: 15710216
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis.
Gelley F; Zadori G; Nemes B; Fassan M; Lendvai G; Sarvary E; Doros A; Gerlei Z; Nagy P; Schaff Z; Kiss A
J Gastroenterol Hepatol; 2014 Jan; 29(1):121-7. PubMed ID: 24033414
[TBL] [Abstract][Full Text] [Related]
14. Management of hepatitis C in HIV infected and other immunocompromised individuals.
Seth AK
Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
[TBL] [Abstract][Full Text] [Related]
15. Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signatures.
Franco S; Buccione D; Pluvinet R; Mothe B; Ruiz L; Nevot M; Jordan-Paiz A; Ramos L; Aussó S; Morillas RM; Sumoy L; Martinez MA; Tural C
Antiviral Res; 2018 Jul; 155():106-114. PubMed ID: 29807039
[TBL] [Abstract][Full Text] [Related]
16. HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization.
Valle-Millares D; Brochado-Kith Ó; Gómez-Sanz A; Martín-Carbonero L; Ryan P; De Los Santos I; Castro JM; Troya J; Mayoral-Muñoz M; Cuevas G; Martínez-Román P; Sanz-Sanz J; Muñoz-Muñoz M; Jiménez-Sousa MÁ; Resino S; Briz V; Fernández-Rodríguez A;
Biomed Pharmacother; 2022 Jan; 145():112405. PubMed ID: 34781145
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional insights into the CD8
Li SY; Zhang ZN; Jiang YJ; Fu YJ; Shang H
J Transl Med; 2020 Feb; 18(1):96. PubMed ID: 32093694
[TBL] [Abstract][Full Text] [Related]
18. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
Thibault PA; Wilson JA
Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
[TBL] [Abstract][Full Text] [Related]
19. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
Castells L; Esteban JI; Bilbao I; Vargas V; Allende H; Ribera E; Piron M; Sauleda S; Len O; Pahissa A; Esteban R; Guardia J; Margarit C
Antivir Ther; 2006; 11(8):1061-70. PubMed ID: 17302376
[TBL] [Abstract][Full Text] [Related]
20. Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection.
Fierer DS; Dieterich DT; Fiel MI; Branch AD; Marks KM; Fusco DN; Hsu R; Smith DM; Fierer J
Clin Infect Dis; 2013 Apr; 56(7):1038-43. PubMed ID: 23264364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
